Crystagen
Also known as Immune bioregulator peptide
A bioregulator peptide product discussed in immune and aging research contexts, with claims centered on immune resilience and cellular regulation rather than a single validated indication.
Overview
Crystagen is part of the bioregulator peptide category and is usually discussed around immune function and aging. It should not be confused with better-characterized single-molecule immunomodulators.
The Science
The hypothesis is that short peptide signals can affect cell regulation and tissue resilience. That broad framing makes evidence quality and product definition especially important.
- Immune regulation - immune-cell function and stress-response themes.
- Aging biology - gerontology and resilience claims.
- Formulation questions - branded bioregulator products may not map cleanly to one sequence.
Evidence Snapshot
Crystagen has limited accessible, high-quality human evidence. It should be presented as a research and product-literacy topic, not as a proven immune intervention.
Related
More in Longevity
5-Amino-1MQ
Research compoundLongevity
Not a peptideSmall molecule
A small-molecule compound that researchers and self-experimenters study for its effects on metabolism, body composition, cellular energy, and healthy aging. Often discussed as a tool for understanding and potentially optimizing metabolic flexibility through NNMT inhibition.
B12
FDA-approvedLongevity
Not a peptideVitamin
An essential water-soluble vitamin required for red blood cell formation, nervous-system function, DNA synthesis, and one-carbon metabolism; it is not a peptide.
Cardiogen
Research compoundLongevity
A short bioregulator peptide discussed in cardiovascular-aging research traditions, usually represented by the tetrapeptide Ala-Glu-Asp-Arg.